Single-Cell Proteomic Characterization of Drug-Resistant Prostate Cancer Cells Reveals Molecular Signatures Associated with Morphological Changes
Molecular & Cellular Proteomics · 2025
DOI: 10.1016/j.mcpro.2025.100949 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular & Cellular Proteomics, 2025. Verfasst von Jongmin Woo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Single-Cell Analysis, Drug Resistance, Neoplasm, Prostatic Neoplasms, Proteomics. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health National Cancer Institute, DOD Prostate Cancer Research Program, U.S. Department of Defense.
Abstract (Originalsprache)
This study delves into the proteomic intricacies of drug-resistant cells (DRCs) within prostate cancer, which are known for their pivotal roles in therapeutic resistance, relapse, and metastasis. Utilizing single-cell proteomics (SCP) with an optimized high-throughput data-independent acquisition (DIA) approach with the throughput of 60 sample per day, we characterized the proteomic landscape of DRCs in comparison to parental PC3 cells. This DIA method allowed for robust and reproducible protein quantification at the single-cell level, enabling the identification and quantification of over 1300 proteins per cell on average. Distinct proteomic sub-clusters within the DRC population were identified, closely linked to variations in cell size. The study uncovered novel protein signatures, including the regulation of proteins critical for cell adhesion and metabolic processes, as well as the upregulation of surface proteins and transcription factors pivotal for cancer progression. Furthermore, by conducting single-cell RNA-seq (scRNA-seq) analysis, we identified six upregulated and 10 downregulated genes consistently altered in drug-treated cells across both SCP and scRNA-seq platforms. These findings underscore the heterogeneity of DRCs and their unique molecular signatures, providing valuable insights into their biological behavior and potential therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Cancer Ecology Center, James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Mar…
- Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Department of Oncology, Johns…
Förderung
- National Institutes of Health National Cancer Institute
- DOD Prostate Cancer Research Program
- U.S. Department of Defense
- Patrick C. Walsh Prostate Cancer Research Fund
- Congressionally Directed Medical Research Programs
- National Institutes of Health
Zitieren
APA
Woo, J., Loycano, M., Amanullah, M., Qian, J., Amend, S. R., Pienta, K. J., & Zhang, H. (2025). Single-Cell Proteomic Characterization of Drug-Resistant Prostate Cancer Cells Reveals Molecular Signatures Associated with Morphological Changes. Molecular & Cellular Proteomics. https://doi.org/10.1016/j.mcpro.2025.100949
Vancouver
Woo J, Loycano M, Amanullah M, Qian J, Amend SR, Pienta KJ, et al. Single-Cell Proteomic Characterization of Drug-Resistant Prostate Cancer Cells Reveals Molecular Signatures Associated with Morphological Changes. Molecular & Cellular Proteomics. 2025. doi:10.1016/j.mcpro.2025.100949
BibTeX
@article{Woo2025,
author = {Woo, Jongmin and Loycano, Michael and Amanullah, Md and Qian, Jiang and Amend, Sarah R and Pienta, Kenneth J and Zhang, Hui},
title = {Single-Cell Proteomic Characterization of Drug-Resistant Prostate Cancer Cells Reveals Molecular Signatures Associated with Morphological Changes},
journal = {Molecular & Cellular Proteomics},
year = {2025},
doi = {10.1016/j.mcpro.2025.100949}
}
EUVIMED